Sign in
Stories
Plasma Fractionation Market Growth
Share
Blood Collection Market Expansion
Blood Health Tools Transform Healthcare
Blood Purification Equipment Market Set ...
Apheresis Equipment Market's Growth Proj...
Cordlife's Accreditation Suspension
Plasma Powder Market Projected to Reach ...
Overview
API
The global plasma fractionation market is set to expand significantly, with a projected CAGR of 6.7% from 2023 to 2031, foreseeing sales revenue of USD 42.6 billion by 2031. Key market players include CSL Behring, Grifols, Takeda Pharmaceutical, and Octapharma, with emerging companies like Kedrion Biopharma and China Biologic also making notable strides. Integration of technologies such as AI and data analytics is bolstering operational efficiency and product safety, while supply chain optimization efforts and cost reduction strategies are heightening market competitiveness.
Ask a question
How could the projected market growth impact healthcare delivery and accessibility globally?
How might the use of AI and data analytics revolutionize the plasma fractionation process?
What strategies can smaller companies employ to compete with major players in the market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage